The Voice of Canadians With Breast Cancer

Education

Our Voices Blog


Category : Taking Action

Taking Action this World Cancer Day

Every year on February 4th, World Cancer Day, we get the opportunity to reflect on the work we’re doing to help reduce the impact of cancer. World Cancer Day, led by the Union for International Cancer Control (UICC), has an action packed slogan: I Am and I Will. They’ve developed a set of key issues that affects us all. Here’s how CBCN is working to reduce the affects of cancer for Canadians based on these key issues:

Our top blogs from 2019!

It’s now 2020! How strange does that sound? 2019 was a busy and impactful year at CBCN. So, we thought we’d look back and see what blogs you, our readers, found to be the most valuable. Here’s the top 10 list of most read blogs on CBCN’s Our Voices.

Biosimilars for Cancer: Recent updates to patient treatments

Over the last few years CBCN has been working to educate patients, physicians and the broader cancer advocacy community about biosimilar therapies.  From our curated digital magazine on biosimilars to our recently released white paper Breast Cancer & Biosimilars: Recommendations on Use, Implementation and Patient Communications-CBCN is committed to raising awareness about the use of biosimilar therapies for treating breast cancer.

How your donations help support those who need it the most

It’s that time of year again! Yesterday you took advantage of all the amazing Cyber Monday deals, gearing up for the holidays and enjoying this festive season with the ones you love. It’s also the time of year where many people start to think about giving to others in need. Since today is Giving Tuesday, we wanted to give you a glimpse into the resources your donations to CBCN help support.

Why should where you live determine your quality of care? Our new campaign highlights the differences in access to treatments for mBC across Canada

Did you know that accessing treatments for stage IV metastatic breast cancer (mBC) is not universal across Canada? We live in a country that promotes universal health care to all but accessing cancer treatment varies by each province.

Pharmacare 2019: Where do Canada’s federal parties stand on a national drug access plan?

Timely access to medications is a key concern for any breast cancer patient, but drug access in Canada has long been a minefield to navigate. Inequitable access to medications across provinces, drug shortages and long wait times to access new treatments are just some of the issues patients and their families routinely encounter in their quest for treatment. National Pharmacare-a plan to reimburse prescription medications in a similar fashion as our healthcare system-has often been proposed as a solution to many of the drug access issues that Canadians currently experience. While Pharmacare has been debated nationally for a long time, it is only recently that the idea has gained real traction and momentum.

An app that helps you during your treatment and beyond

Self-care during treatment is so important for maintaining not only a good quality of life but your sanity as well. From doctors appointments, to managing the emotional aspects of a breast cancer diagnosis, there’s a lot to juggle. We’re excited to announce our new partnership with Self Care Catalysts and our Health Storylines mobile app.

Here’s what you need to know about the federal government’s Implementation of National Pharmacare report

On June 12th, the Advisory Council on the Implementation of National Pharmacare released their final report looking at the implementation of a national program to address the inequities that Canadians currently face when it comes to drug access. It outlines 60 recommendations, steps to implementation and key details on things like co-pay, budget costs, strategy for rare diseases, and impacts on patients and providers. Below, we’ve summarized these key details for you to better understand how this new plan for pharmacare would impact you and your family. 

Our new white paper: what are patients and physicians saying about biosimilars in breast cancer?

We talked a lot on this blog last year about biosimilars; what they are and why it’s important to know about them. With the entry of biosimilars in the breast cancer treatment landscape due later this year, there are still questions and discussions about how it will affect current and future breast cancer patients. To help understand these questions and perspectives, we decided it was important to bring together those people who are impacted the most: patients and physicians.

How can we ease the financial burden of breast cancer?

When you are first told you have breast cancer, your thoughts can immediately turn to your mortality and how to best save your life. You worry about how your diagnosis will affect your family, spouse or kids. More and more, the realities of the disease begin to set in and the impact it can have on your finances becomes more apparent.